Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Asian J Psychiatr. 2024 Feb 12;94:103965. doi: 10.1016/j.ajp.2024.103965. Online ahead of print.
ABSTRACT
BACKGROUND AND HYPOTHESIS: The Positive and Negative Syndrome Scale (PANSS) consists of 30 items and takes up to 50 minutes to administer and score. Therefore, this study aimed to develop and validate a machine learning-based short form of the PANSS (PANSS-MLSF) that reproduces the PANSS scores. Moreover, the PANSS-MLSF estimated the removed-item scores.
STUDY DESIGN: The PANSS-MLSF was developed using an artificial neural network, and the removed-item scores were estimated using the eXtreme Gradient Boosting classifier algorithm. The reliability of the PANSS-MLSF was examined using Cronbach’s alpha. The concurrent validity was examined by the association (Pearson’s r) between the PANSS-MLSF and the PANSS. The convergent validity was examined by the association (Pearson’s r) between the PANSS-MLSF and the Clinical Global Impression-Severity, Mini-Mental State Examination, and Lawton Instrumental Activities of Daily Living Scale. The agreement of the estimated removed-item scores with their original scores was examined using Cohen’s kappa.
STUDY RESULTS: Our analysis included data from 573 patients with moderate severity. The two versions of the PANSS-MLSF comprised 15 items and 9 items were proposed. The PANSS-MLSF scores were similar to the PANSS scores (mean squared error=2.6-24.4 points). The reliability, concurrent validity, and convergent validity of the PANSS-MLSF were good. Moderate to good agreement between the estimated removed-item scores and the original item scores was found in 60% of the removed items.
CONCLUSION: The PANSS-MLSF offers a viable way to reduce PANSS administration time, maintain score comparability, uphold reliability and validity, and even estimate scores for the removed items.
PMID:38394743 | DOI:10.1016/j.ajp.2024.103965
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 5 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Developing a machine learning-based short form of the positive and negative syndrome scale
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach The Effects of Art Therapy and Psychosocial Skills Training on Symptoms and Social Functioning in Patients with Schizophrenia and Their Relatives The effect of cognitive impairment based on Mini-Mental State Examination (MMSE) on suicidal tendency in patients with schizophrenia: A large cross-sectional study A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models Variations to plasma H(2)O(2) levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome Mapping Brain Synergy Dysfunction in Schizophrenia: Understanding Individual Differences and Underlying Molecular Mechanisms Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia Gender difference in the relationship between clinical symptoms, thyroid hormones, and metabolic parameters in young, first-episode and drug-naive major depressive disorder patients with suicide attempts: A network analysis perspective Sex-specific associations of plasma neutrophil gelatinase-associated lipocalin (NGAL) with cognition in patients with drug-naive schizophrenia Using machine learning to develop a five-item short form of the children's depression inventory Relationship between plasma risperidone concentrations and clinical features in chronic schizophrenic patients in China Computerized cognitive remediation therapy on cognitive impairment and social function in patients with chronic schizophrenia Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses Contribution of copy number variants on antipsychotic treatment response in Han Chinese patients with schizophrenia Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial Short-term antipsychotic treatment reduces functional connectivity of the striatum in first-episode drug-naive early-onset schizophrenia The Mediating Role of Anxiety/Depression Between Auditory Verbal Hallucinations and the Level of Insight in Schizophrenia Patients with schizophrenia in Morocco during the COVID-19 pandemic: a longitudinal observational study Patients with schizophrenia in Morocco during the COVID-19 pandemic: a longitudinal observational study Neurocognitive function and delusion severity in schizophrenia spectrum disorders Electroencephalographic differences in patients with paranoid schizophrenia with or without a history of suicide attempts A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia A 12-month longitudinal naturalistic follow-up of cariprazine in schizophrenia Adaptation of the Child sexual abuse myth scale to Turkish culture: A reliability and validity study Eveningness chronotype influences social functioning by deteriorating depressive symptoms in remitted patients with schizophrenia Association between childhood maltreatment and suicidal ideation among Chinese patients with chronic schizophrenia: the mediating role of insomnia Assessment of symptom severity in psychotic disorder patients based on heart rate variability and accelerometer mobility data Effect of psychological nursing interventions on effectiveness and quality of life in schizophrenia patients receiving modified electroconvulsive therapy Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorder Association of serum interleukin-6 with negative symptoms in stable early-onset schizophrenia Network analysis of comorbid aggressive behavior and testosterone among bipolar disorder patients: a cross-sectional study NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients Duration of untreated psychosis and its associated sociodemographic and clinical factors in first-episode psychosis: A study from Eastern Nepal In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18-Labeled THK5351 Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study The Effectiveness of the 4P Nursing Model Combined with Amisulpride and Clozapine in the Management of Psychiatric Patients The Effectiveness of the 4P Nursing Model Combined with Amisulpride and Clozapine in the Management of Psychiatric Patients Influence of White Sound on Sleep Quality, Anxiety, and Depression in Patients with Schizophrenia Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom-Dominant Psychosis Gender differences in cognitive improvements after two months of atypical antipsychotic treatment in first episode schizophrenia Assessment of resting cerebral perfusion between methamphetamine-associated psychosis and schizophrenia through arterial spin labeling MRI The association of prolactin and gonadal hormones with cognition and symptoms in men with schizophrenia spectrum disorder: Divergent effects of testosterone and estrogen Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials Disorganization in individuals at clinical high risk for psychosis: psychopathology and treatment response Disorganization in individuals at clinical high risk for psychosis: psychopathology and treatment response D-serine and D-amino acid oxidase levels in patients with schizophrenia spectrum disorders in the first episode and 6-month follow-up Interleukin-1β moderates the relationships between middle frontal- mACC /insular connectivity and depressive symptoms in bipolar II depression Prevalence of metabolic syndrome and its associated factors in first-treatment drug-naive schizophrenia patients: A large-scale cross-sectional study Development and Validation of the Five-Factor Borderline Inventory-Super Short Form and Screener Development and Validation of the Five-Factor Borderline Inventory-Super Short Form and Screener Machine learning approach for the development of a crucial tool in suicide prevention: The Suicide Crisis Inventory-2 (SCI-2) Short Form Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort Comparative analysis of resting-state EEG-based multiscale entropy between schizophrenia and bipolar disorder Psychometric Properties and Measurement Invariance of the Awareness of Age-Related Change Short Form in Older Adult Samples from Taiwan and Germany Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation
Evidence Blueprint
Developing a machine learning-based short form of the positive and negative syndrome scale
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Developing a machine learning-based short form of the positive and negative syndrome scale
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Relationship between blood-based inflammatory indices and clinical score of schizophrenia patients: A cross-sectional study Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia The Therapeutic Role of Intermittent Theta Burst Stimulation in Schizophrenia: A Systematic Review and Meta-analysis Relationships among the gut microbiome, brain networks, and symptom severity in schizophrenia patients: A mediation analysis Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions Efficacy and feasibility of aerobic exercise interventions as an adjunctive treatment for patients with schizophrenia: a meta-Analysis Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia Psychomotor slowing in schizophrenia is associated with cortical thinning of primary motor cortex: A three cohort structural magnetic resonance imaging study Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis The Relationship Between Depressive Symptoms and Psychological Variables in Patients With Schizophrenia The Effects of Art Therapy and Psychosocial Skills Training on Symptoms and Social Functioning in Patients with Schizophrenia and Their Relatives The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia Sex-differential association of suicide attempts with thyroid dysfunction in first-episode and drug-naïve young major depressive disorder patients with comorbid anxiety The effect of cognitive impairment based on Mini-Mental State Examination (MMSE) on suicidal tendency in patients with schizophrenia: A large cross-sectional study From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models Variations to plasma H(2)O(2) levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology A multicenter, single-arm, open-label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis Gender differences in prevalence and clinical risk factors of suicide attempts in young adults with first-episode drug-naive major depressive disorder Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients… Mapping Brain Synergy Dysfunction in Schizophrenia: Understanding Individual Differences and Underlying Molecular Mechanisms Association of empathy with clinical symptoms and cognitive function in chronic schizophrenia patients with and without suicide attempts Systematic Review and Meta-analysis of Exercise Interventions for Psychotic Disorders: The Impact of Exercise Intensity, Mindfulness Components, and Other Moderators on Symptoms, Functioning, and Cardiometabolic Health Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms Gender difference in the relationship between clinical symptoms, thyroid hormones, and metabolic parameters in young, first-episode and drug-naive major depressive disorder patients with suicide attempts: A network analysis perspective Cognitive Inflexibility Predicts Negative Symptoms Severity in Patients with First-Episode Psychosis: A 1-Year Follow-Up Study Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study Sex-specific associations of plasma neutrophil gelatinase-associated lipocalin (NGAL) with cognition in patients with drug-naive schizophrenia Using machine learning to develop a five-item short form of the children's depression inventory Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia: a comprehensive cross-sectional study Serum S100B Protein and White Matter Changes in Schizophrenia before and after Medication Relationship between plasma risperidone concentrations and clinical features in chronic schizophrenic patients in China Further clarification of cognitive processes of prospective memory in schizophrenia by comparing eye-tracking and ecologically-valid measurements Effects of mind-body therapies on schizophrenia: A systematic review and network meta-analysis Prevalence and correlates of suicide attempts in young patients with first-episode and drug-naïve major depressive disorder: A large cross-sectional study Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review Computerized cognitive remediation therapy on cognitive impairment and social function in patients with chronic schizophrenia The effect of online group based acceptance and commitment therapy on psychotic symptoms and functioning levels of individuals with early psychosis The effect of repetitive transcranial magnetic stimulation on the negative symptoms of chronic schizophrenia and serum brain-derived neurotrophic factor The Effect of an Emotion Recognition and Expression Program on the Alexithymia, Emotion Expression Skills and Positive and Negative Symptoms of Patients with Schizophrenia in a Community Mental Health Center Developing a Short-Form Buss-Warren Aggression Questionnaire Based on Machine Learning Smartphone video games improve cognitive function in patients with chronic schizophrenia: a randomized controlled trial Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis Navigated and individual α-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia The effect of functional remission and cognitive insight on criminal behavior in patients with schizophrenia Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia Contribution of copy number variants on antipsychotic treatment response in Han Chinese patients with schizophrenia Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial Relationship between drug-induced movement disorders and psychosis in adults living in precarious housing or homelessness Short-term antipsychotic treatment reduces functional connectivity of the striatum in first-episode drug-naive early-onset schizophrenia